Rumored Buzz on Healthcare News
Novo CEO pressed by Senate to chop costs of weight problems, diabetic issues drugs CEO Lars Fruergaard Jørgensen advised lawmakers the corporation would consider new talks with insurers in regards to the record rates of Wegovy and copyright when they pledge to maintain the medicines on their own formularies.Sanders quickly condemned the go in a pr